Quality & complianceOfficial

Denmark flags supply problems for Dechra's Euthasol vet. pentobarbital injection amid manufacturing issues

🇩🇰 DKMA · Wed 28 Oct 2026

The Danish Medicines Agency says Euthasol vet. 400 mg/ml is affected by production problems, with disruption expected from late September to early November 2026.

The Danish Medicines Agency (DKMA) has published a supply notice for Euthasol vet. 400 mg/ml solution for injection, a veterinary medicine marketed by Dechra Veterinary Products A/S. The notice was first posted on 9 July 2026 and updated on 28 October 2026.

The product's active substance is pentobarbital, as pentobarbital sodium, and its ATC vet code is QN51AA01. DKMA gives the cause of the supply difficulty as production problems.

The agency lists the expected period of disruption as end of September to the start of November 2026. The notice does not say how many packs or batches are affected, and it names no alternative products or measures.

DKMA directs questions about the current status to the company. The notice appears in the agency's section on medicine supply announcements, under veterinary products for 2026.

What it means for your team

  • Veterinary supply chain and pharmacy teams in Denmark should check current availability of Euthasol vet. 400 mg/ml directly with Dechra Veterinary Products A/S.
  • The notice gives no information on alternatives or on any change to the expected end of the disruption, so contingency planning rests with the companies and users concerned.
  • Regulatory and supply teams may wish to follow DKMA's supply announcements page for further updates, since this entry has already been revised once.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →